Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
A market cap of 400-500 million seems justified after the deal closes. Puts the pps of at least 3.5 -4.00 is likely. That will get them on NASDAQ!
Aviptadil
This stock had one of the most amazing runs at the end of 2019.
Trips to .40 in 6 weeks.
This run will top that one!!
Who is in front of us and with what drug! Is there one drug ahead of us as effective as RLF-100?
I believe it!
You’re right. It was $3 Bil!!
Yes...OTC stocks can be volatile!!
4B is a lot better than 5B!!
The public is anti vaccine. If the public knows there is a cure even less will be taking the vaccine including me. Big PHARM does not like cures
40 million already traded in Switzerland. Up 18%!!
RLF-100 should have gotten an EUA already. Not one other drug in trials has the success rate of RLF-100. Is big pharma putting pressure on the FDA not to give us an EUA? I think so. Their focus has been on the vaccines. I’m sure Dr J is as frustrated as we are, but of course he can’t say so publicly!
RLF moving higher again in Swiss markets. Dr. J speaking Wednesday at a major world conference. December will be our month.
Maybe when it’s at $2.00 you will finally understand!!
Looks like I’ll be averaging up again on Monday!!
See you at $2.00!!!’
You never know when they let it run! If not today, it’ll be next week! Nobody has a perfect crystal ball
This is way beyond the pikers on iHub!
.10s Close
All attempts for a sell off have failed! Buyers step in !!
Going much higher!!
Averaging up again!!
Massive squeeze during power hour will close it over .10!!
No one got kicked anywhere. It’s no secret GEM had these warrants. They’re entitled to exercise these warrants. But it’s good news because it shows they believe FDA approval is getting closer. GEM is entitled to get paid back on their investment and their not looking to sell these shares at .34. They’re looking to sell them at multi dollars!!
If GEM exercised the warrants, we must be getting close to EUA!!
Loving this bloated pig!! $$$$$
I’m lovin this scam!!
The buyers keep coming!!
Almost 2,000 Covid 19 deaths in the US yesterday. Why is the FDA holding up EUA for RLF-100?
From the way it traded yesterday, you would have to guess more good news is imminent!!
Many unanswered questions remain about the vaccine:
“It’s also unknown whether any of the 94 coronavirus patients had underlying risk factors. That data matters because state and county officials are prioritizing high-riskand socially vulnerable groups during the first distribution waves. “It’s not clear in the trial who got the vaccine,” says Paul Offit, director of the Vaccine Education Center at Children’s Hospital of Philadelphia and a member of the FDA’S COVID-19 advisory committee. “You wonder whether those groups of people were adequately represented.”
I still think we get an EUA before the study is completed. With the halt of the China vaccine, RLF-100 is needed more than ever worldwide. And if there is a sudden side effect discovered in the Pfizer vaccine, RLFTF will surge.
Another vaccine gets halted :
https://www.bbc.co.uk/news/world-asia-china-54883383
There will still be a great need for RLF-100! 50% or more of the population will refuse to take the vaccine and the virus may mutate making the vaccine ineffective.
“In addition to the financial benefits to the company, shareholders and Investors, the contract increased the need for the company to expand operations and the requirement for additional staff to oversee all aspects of the company’s rapid growth.”
RLF-100 received Fast Track designation from the FDA in June. Hopefully, now that election is over, we get EUA before the study is completed in mid December. Part of Fast Track is that the company is in constant communication with FDA. Which means Dr. J has been talking to the FDA frequently since June .
The bottom line is this statement from the last PR:
“Currently, there is no approved drug that has shown efficacy in this population, nor are there late stage trials of other experimental therapeutics focusing on these patients.”
The population being the most critically ill!
Aviptadil is a winner and will save thousands of lives.
A milly on the bid!!
I would think there will be more follow up news on this deal shortly. A lot of details are unknown!
Closing price today was .0587 up 131%. And that is final!
The .0668 trade was from earlier in the day that never printed in a fast market. It will changed from the closing price a little later in the evening
Well, 1% of a billy is $10 million!! But it could a lot more than 1%! They did say they had to expand operations and hire more staff so it sounds like they are more than just middleman.
What is the short position here?